Related Experiment Videos
Anal carcinoma or "just hemorrhoids"?
1Department of Surgery, Medical College of Georgia Hospital and Clinics, Augusta 30912-4004, USA.
The American Surgeon
|December 4, 2001
Summary
Anal cancers are rare, often misdiagnosed, and frequently present at advanced stages. Early detection and treatment are crucial for improving outcomes, especially for aggressive anal melanoma.
Area of Science:
- Oncology
- Gastroenterology
Background:
- Anal cancers, including those of the anal margin and canal, are rare gastrointestinal malignancies.
- These cancers are often misdiagnosed, contributing to late-stage presentation.
Purpose of the Study:
- To review the diagnosis, staging, treatment, survival, and recurrence rates of anal cancer patients.
- To evaluate the effectiveness of different treatment modalities for anal cancer.
Main Methods:
- Retrospective review of 50 anal cancer cases diagnosed between January 1985 and July 2000.
- Analysis of patient charts for demographic, diagnostic, staging, treatment, and outcome data.
Main Results:
- Squamous cell carcinoma was the most common histology (88%).
- A significant proportion of patients presented with advanced disease (Stage III/IV: 30%).
- Chemoradiotherapy was the primary treatment for 50% of patients; 20% underwent abdominoperineal resection (APR).
- The overall mortality rate was 36%, with anal melanoma showing particularly high fatality.
Conclusions:
- Anal cancers frequently present at advanced stages, leading to a high mortality rate.
- Anal melanoma is an aggressive cancer with a poor prognosis.
- Abdominoperineal resection (APR) is a recommended salvage therapy for advanced anal carcinomas.
- Early recognition and detection of primary and recurrent anal cancer are essential for improved patient outcomes.